Back to News
Market Impact: 0.15

Why This Hedge Fund Added $29 Million to a Cancer Stock Already Up 700%

ERAS
Insider TransactionsHealthcare & BiotechInvestor Sentiment & Positioning

New York-based Siren bought 2,486,997 shares of Erasca in the first quarter, an estimated $29.39 million transaction based on average first-quarter 2026 prices. The filing reflects a notable position increase but provides no operational or earnings update. Impact is likely limited to sentiment around the stock rather than broad market implications.

Analysis

New York-based Siren bought 2,486,997 shares of Erasca in the first quarter, an estimated $29.39 million transaction based on average first-quarter 2026 prices. The filing reflects a notable position increase but provides no operational or earnings update. Impact is likely limited to sentiment around the stock rather than broad market implications.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.10

Ticker Sentiment

ERAS0.10